Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (15,2 Mio. €): Cities@Heart: Stadtbasierte Strategien zur Verbesserung der Herz-Kreislauf-Gesundheit in Europa Hor 01.01.2026 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

Cities@Heart: Stadtbasierte Strategien zur Verbesserung der Herz-Kreislauf-Gesundheit in Europa

Cardiovascular disease (CVD) prevention and management strategies are effective but poorly implemented, especially in urban and underserved communities that would benefit the most. Cities@Heart aims to develop, pilot, and evaluate strategies that will reduce both the burden of CVD and health inequalities. Building on the existing European Healthy Cities Network by partner World Health Organization (WHO), and work by the World Heart Federation, European Society of Cardiology, European Public Health Association and HL7 Europe, we will provide a solid infrastructure that embeds innovative health technology to ensure scalability and sustainability. Cities@Heart will focus on obesity, hypertension, dyslipidaemia and diabetes as key drivers of CVD that can leverage engagement and citizen empowerment. We will develop and deploy derivation and implementation pilots for CVD awareness, effective prevention, early detection, and optimal management at the urban level. The municipalities of Izmir (Turkey), Belfast (Northern Ireland), Łódź (Poland), Cork (Republic of Ireland), Udine (Italy), Birmingham (England) and Utrecht (Netherlands) have diverse communities with differing health inequalities, with a commitment and past experience to deploy multi-disciplinary health strategies.  Together with citizen and industry co-creation, these cities will apply a structured, multi-sector methodology that includes: (1) city-level approaches to reduce the burden of CVD; (2) a digital ecosystem that will power the development of European health technology and economic growth, (3) integration of health policy and health economics to deliver cost-effective city-level solutions; and (4) sustainability at its core using an implementation framework that can apply across European cities.  Cities@Heart will build connections and capacity across our broad array of stakeholders through a strong public-private partnership. Together, we will support the next generation of health technology to address critical barriers for optimal CVD care in Europe.


Geförderte Unternehmen:

Firmenname Förderungssumme
A. Menarini Farmaceutica Internazionale Srl ?
Belfast City Council 75.000 €
Birmingham City Council 75.000 €
Collaborate Project Management GmbH 250.000 €
Comune Di Udine 75.000 €
Cork City Council 75.000 €
Daiichi Sankyo Europe GmbH 0,00 €
EGE Universitesi 99.166 €
European Heart Network Aisbl 199.999 €
European Public Health Association 79.908 €
Gemeente Utrecht 75.000 €
Health Service Executive 20.000 €
HL7 Europe 285.000 €
Huawei Technologies OY (Finland) CO Ltd. 0,00 €
Instytut Centrum Zdrowia Matki Polki 214.709 €
Izmir Buyuksehir Belediyesi 75.000 €
Lodz-Miasto NA Prawach Powiatu 75.000 €
London School of Economics and Political Science 516.548 €
Menarini Ricerche S.p.A. 0,00 €
Novartis Pharma AG 0,00 €
Novo Nordisk A/S 0,00 €
Panepistimio Kritis 215.000 €
SE de Cardiologie 315.729 €
Servier Affaires Medicales 0,00 €
The Queen's University of Belfast 474.986 €
The University of Birmingham 1.686.474 €
The University of Edinburgh 279.963 €
Universita Degli Studi Di Udine 100.000 €
Universitair Medisch Centrum Utrecht 8.062.804 €
Universiteit Antwerpen 706.360 €
University College Cork - National University of Ireland, Cork 414.918 €
Wavy Assistant B.V. 299.375 €
World Health Organization 415.000 €

Quelle: https://cordis.europa.eu/project/id/101219389

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: A.Menarini Farmaceutica Internazionale Srl, Florenz, Italien.